Analysis of transcriptional regulation by progesterone receptor in ER-positive breast cancer cells by ChIP-Seq

被引：0
|
作者：
Yang, Fan
Bilke, Sven
Pineda, Marbin
Walker, Bob
Zhu, Jack
Meltzer, Paul
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/1538-7445.AM10-4612
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4612
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Targeting estrogen to kill ER-positive and ER-negative breast cancer
    VC Jordan
    Breast Cancer Research, 7
  • [42] An estrogen receptor (ER)-related signature in predicting prognosis of ER-positive breast cancer following endocrine treatment
    Tang, Jianing
    Cui, Qiuxia
    Zhang, Dan
    Liao, Xing
    Zhu, Jian
    Wu, Gaosong
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (08) : 4980 - 4990
  • [43] Estrogen-induced interaction between KLF5 and estrogen receptor (ER) suppresses the function of ER in ER-positive breast cancer cells
    Guo, Peng
    Dong, Xue-Yuan
    Zhao, Ke-Wen
    Sun, Xiaodong
    Li, Qunna
    Dong, Jin-Tang
    INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (01) : 81 - 89
  • [44] The prognostic effects of somatic mutations in ER-positive breast cancer
    Griffith, Obi L.
    Spies, Nicholas C.
    Anurag, Meenakshi
    Griffith, Malachi
    Luo, Jingqin
    Tu, Dongsheng
    Yeo, Belinda
    Kunisaki, Jason
    Miller, Christopher A.
    Krysiak, Kilannin
    Hundal, Jasreet
    Ainscough, Benjamin J.
    Skidmore, Zachary L.
    Campbell, Katie
    Kumar, Runjun
    Fronick, Catrina
    Cook, Lisa
    Snider, Jacqueline E.
    Davies, Sherri
    Kavuri, Shyam M.
    Chang, Eric C.
    Magrini, Vincent
    Larson, David E.
    Fulton, Robert S.
    Liu, Shuzhen
    Leung, Samuel
    Voduc, David
    Bose, Ron
    Dowsett, Mitch
    Wilson, Richard K.
    Nielsen, Torsten O.
    Mardis, Elaine R.
    Ellis, Matthew J.
    NATURE COMMUNICATIONS, 2018, 9
  • [45] Regulation of HER3 protein degradation in ER-positive breast cancer cell.
    Suga, Junko
    Tanaka, Nobuyuki
    Saji, Shigehira
    CANCER SCIENCE, 2018, 109 : 521 - 521
  • [46] ER-positive breast cancer cells are poised for RET-mediated endocrine resistance
    Horibata, Sachi
    Rice, Edward J.
    Mukai, Chinatsu
    Marks, Brooke A.
    Sams, Kelly
    Zheng, Hui
    Anguish, Lynne J.
    Coonrod, Scott A.
    Danko, Charles G.
    PLOS ONE, 2018, 13 (04):
  • [47] The prognostic effects of somatic mutations in ER-positive breast cancer
    Obi L. Griffith
    Nicholas C. Spies
    Meenakshi Anurag
    Malachi Griffith
    Jingqin Luo
    Dongsheng Tu
    Belinda Yeo
    Jason Kunisaki
    Christopher A Miller
    Kilannin Krysiak
    Jasreet Hundal
    Benjamin J Ainscough
    Zachary L. Skidmore
    Katie Campbell
    Runjun Kumar
    Catrina Fronick
    Lisa Cook
    Jacqueline E. Snider
    Sherri Davies
    Shyam M. Kavuri
    Eric C. Chang
    Vincent Magrini
    David E. Larson
    Robert S Fulton
    Shuzhen Liu
    Samuel Leung
    David Voduc
    Ron Bose
    Mitch Dowsett
    Richard K. Wilson
    Torsten O. Nielsen
    Elaine R Mardis
    Matthew J. Ellis
    Nature Communications, 9
  • [48] Stereotactic radiotherapy for oligoprogressive ER-positive breast cancer (AVATAR)
    Reem Alomran
    Michelle White
    Melissa Bruce
    Mathias Bressel
    Susan Roache
    Lama Karroum
    Gerard G. Hanna
    Shankar Siva
    Shom Goel
    Steven David
    BMC Cancer, 21
  • [49] A gene signature of loss of oestrogen receptor (ER) function and oxidative stress links ER-positive breast tumours with an absent progesterone receptor and a poor prognosis
    Patrick Neven
    Toon Van Gorp
    Karen Deraedt
    Breast Cancer Research, 10
  • [50] Attenuation of ER expression in the ER-positive breast cancer organoids by passages in vitro
    Uematsu, Hiroyuki
    Onuma, Kunishige
    Sugie, Tomoharu
    Inoue, Masahiro
    CANCER SCIENCE, 2023, 114 : 1387 - 1387
12345